glp 1 weight loss no insurance coverage just changed for as many as 56 million Americans when it comes to the popular GLP-1 medications used to promote loss. Read more: https://thehill.com/policy/healthcare/5972729-glp-1-insurance-change-impacts-millions-of Got a GLP-1 coverage denial

We included adults with type 2 diabetes who initiated a GLP-1 RA (exenatide [introduced in Israel in 12.2007], liraglutide [2.2010], lixisenatide [1.2015], exenatide extended-release [11.2015], dulaglutide [4.2016], and semaglutide [8.2019]) or basal insulin between February 2010 to December 2019

For now, and in the context of GLP therapy, it will be important to first better understand the insulin release and response kinetics in normal weight, nondiabetic patients before recommending these meds for a broader population.

Similarly, Sahin et al

COMT and MTHFR polymorphisms interaction on cognition in schizophrenia: an exploratory study